NCT02909556View on ClinicalTrials.gov

ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 16, 2016

Primary Completion Date

January 24, 2018

Study Completion Date

January 13, 2023

Conditions

Aortic Stenosis

Interventions

DEVICE

Transcatheter aortic valve replacement

Transcatheter aortic valve replacement via transfemoral access

Trial Locations (9)

2100

Rigshospitalet, Copenhagen

6000

Luzerner Kantonsspital, Lucerne

20246

Universitäres Herzzentrum Hamburg - Klinik und Poliklinik für Herz- und Gefäßchirurgie, Hamburg

61231

Kerckhoff-Klinik Forschungsgesellschaft mbH, Bad Nauheim

80636

Deutsches Herzzentrum München, München

93053

Universitätsklinik Regensburg, Regensburg

Unknown

Johannes Hospital, Dortmund

06120

Universitätsklinikum Halle - Universitätsklinik und Poliklinik für Herzchirurgie, Halle

04289

Herzzentrum Leipzig GmbH, Leipzig

All Listed Sponsors

lead

Symetis SA

INDUSTRY

NCT02909556 - ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis | Biotech Hunter | Biotech Hunter